Chitra Subramanian

2.5k total citations
73 papers, 1.9k citations indexed

About

Chitra Subramanian is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chitra Subramanian has authored 73 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Chitra Subramanian's work include Heat shock proteins research (12 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Phytochemicals and Medicinal Plants (8 papers). Chitra Subramanian is often cited by papers focused on Heat shock proteins research (12 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Phytochemicals and Medicinal Plants (8 papers). Chitra Subramanian collaborates with scholars based in United States, India and Singapore. Chitra Subramanian's co-authors include Erle S. Robertson, Murray A. Cotter, Mark S. Cohen, Anthony W. Opipari, Roland P.S. Kwok, Valerie P. Castle, Peter White, Ke Lan, Xin Bian and Brian S. J. Blagg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Chitra Subramanian

71 papers receiving 1.9k citations

Peers

Chitra Subramanian
Xiaohe Yang United States
Sumit Siddharth India
Shiquan Liu China
Frederik H. Igney Germany
Yurai Okaji Japan
Suparna Mazumder United States
Ling‐Wen Ding Singapore
Pulicat Manogaran Saudi Arabia
Mengsen Li China
Xiaohe Yang United States
Chitra Subramanian
Citations per year, relative to Chitra Subramanian Chitra Subramanian (= 1×) peers Xiaohe Yang

Countries citing papers authored by Chitra Subramanian

Since Specialization
Citations

This map shows the geographic impact of Chitra Subramanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chitra Subramanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chitra Subramanian more than expected).

Fields of papers citing papers by Chitra Subramanian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chitra Subramanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chitra Subramanian. The network helps show where Chitra Subramanian may publish in the future.

Co-authorship network of co-authors of Chitra Subramanian

This figure shows the co-authorship network connecting the top 25 collaborators of Chitra Subramanian. A scholar is included among the top collaborators of Chitra Subramanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chitra Subramanian. Chitra Subramanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Subramanian, Chitra, et al.. (2025). C‐Terminal Hsp90 Inhibitors Overcome MEK and BRAF Inhibitor Resistance in Melanoma. Journal of Cellular and Molecular Medicine. 29(6). e70489–e70489. 1 indexed citations
2.
Subramanian, Chitra, et al.. (2024). The Investigation of Hsp90C‐Terminal Inhibitors Containing Amide Bioisosteres. ChemMedChem. 19(24). e202400418–e202400418.
3.
Subramanian, Chitra, Daniel L. Hess, Katja Kiseljak‐Vassiliades, et al.. (2024). Novel repurposing of sulfasalazine for the treatment of adrenocortical carcinomas, probably through the SLC7A11/xCT-hsa-miR-92a-3p-OIP5-AS1 network pathway. Surgery. 177. 108832–108832. 3 indexed citations
4.
Kang, Yoon‐Tae, Ji‐Young Kim, Emine Sumeyra Turali Emre, et al.. (2024). Chiroptical detection and mutation analysis of cancer-associated extracellular vesicles using microfluidics with oriented chiral nanoparticles. Matter. 7(12). 4373–4389. 8 indexed citations
5.
Purcell, Emma, Sarah Owen, Ting‐Wen Lo, et al.. (2021). Epidermal Growth Factor Receptor Mutations Carried in Extracellular Vesicle-Derived Cargo Mirror Disease Status in Metastatic Non-small Cell Lung Cancer. Frontiers in Cell and Developmental Biology. 9. 724389–724389. 11 indexed citations
6.
Subramanian, Chitra & Mark S. Cohen. (2021). Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics. Surgery. 171(1). 119–129. 9 indexed citations
7.
Wang, Ton, Chitra Subramanian, Minzhi Yu, et al.. (2019). Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer. Surgery. 166(6). 1168–1175. 10 indexed citations
8.
Wang, Ton, Chitra Subramanian, Brian S. J. Blagg, & Mark S. Cohen. (2019). A novel heat shock protein 90 inhibitor potently targets adrenocortical carcinoma tumor suppression. Surgery. 167(1). 233–240. 5 indexed citations
9.
Khandelwal, Anuj, Shuxia Peng, Sanket J. Mishra, et al.. (2018). Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor. Nature Communications. 9(1). 425–425. 90 indexed citations
10.
Subramanian, Chitra & Mark S. Cohen. (2018). Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma. Surgery. 165(1). 202–210. 17 indexed citations
11.
Subramanian, Chitra, Kevin J. Kovatch, Michael W. Sim, et al.. (2017). Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells. Neoplasia. 19(12). 1003–1011. 28 indexed citations
12.
White, Peter, Chitra Subramanian, Hashim F. Motiwala, & Mark S. Cohen. (2016). Natural Withanolides in the Treatment of Chronic Diseases. Advances in experimental medicine and biology. 928. 329–373. 93 indexed citations
13.
Subramanian, Chitra, Jason A. Jarzembowski, Rork Kuick, et al.. (2010). CLU blocks HDACI-mediated killing of neuroblastoma. Tumor Biology. 32(2). 285–294. 5 indexed citations
14.
Srinivasan, K., et al.. (2007). Phytochemical screening and antibacterial evaluation of stem bark of Mallotus philippinensis var. Tomentosus. AFRICAN JOURNAL OF BIOTECHNOLOGY. 6(13). 1521–1523. 21 indexed citations
15.
Subramanian, Chitra, Jason A. Jarzembowski, Anthony W. Opipari, Valerie P. Castle, & Roland P.S. Kwok. (2007). CREB-Binding Protein Is a Mediator of Neuroblastoma Cell Death Induced By the Histone Deacetylase Inhibitor Trichostatin A. Neoplasia. 9(6). 495–503. 20 indexed citations
16.
Sundberg, Thomas B., Gina M. Ney, Chitra Subramanian, Anthony W. Opipari, & Gary D. Glick. (2006). The Immunomodulatory Benzodiazepine Bz-423 Inhibits B-Cell Proliferation by Targeting c-Myc Protein for Rapid and Specific Degradation. Cancer Research. 66(3). 1775–1782. 27 indexed citations
17.
Subramanian, Chitra, Anthony W. Opipari, Valerie P. Castle, & Roland P.S. Kwok. (2005). Histone Deacetylase Inhibition Induces Apoptosis in Neuroblastoma. Cell Cycle. 4(12). 1741–1743. 6 indexed citations
18.
Subramanian, Chitra. (2002). The Epstein Barr Nuclear Antigen EBNA3C regulates transcription, cell transformation and cell migration. Frontiers in bioscience. 7(1-3). d704–d704. 25 indexed citations
19.
20.
Cotter, Murray A., et al.. (2001). Prothymosin α Functions as a Cellular Oncoprotein by Inducing Transformation of Rodent Fibroblasts in Vitro. Journal of Biological Chemistry. 276(3). 1794–1799. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaohe Yang Breakdown of academic impact, for papers by Sumit Siddharth Breakdown of academic impact, for papers by Shiquan Liu Breakdown of academic impact, for papers by Frederik H. Igney Breakdown of academic impact, for papers by Yurai Okaji Breakdown of academic impact, for papers by Suparna Mazumder Breakdown of academic impact, for papers by Ling‐Wen Ding Breakdown of academic impact, for papers by Pulicat Manogaran Breakdown of academic impact, for papers by Mengsen Li
Rankless by CCL
2026